{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:37:29Z","timestamp":1780529849606,"version":"3.54.1"},"reference-count":52,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cardiovasc Pharmacol Ther"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>\n                    Cangrelor is an intravenously administered P2Y\n                    <jats:sub>12<\/jats:sub>\n                    receptor antagonist with very fast, potent, and quickly reversible action. In the CHAMPION PHOENIX trial, cangrelor provided an improved anti-ischemic protection compared with clopidogrel, without increasing the risk of severe bleeding. Cangrelor is currently approved by drug regulating authorities for patients undergoing percutaneous coronary intervention (PCI) without prior treatment with a P2Y\n                    <jats:sub>12<\/jats:sub>\n                    receptor antagonist and not receiving a glycoprotein IIb\/IIIa inhibitor, while its use is endorsed with a class IIb recommendation by the European Society of Cardiology guidelines. Several subanalyses of CHAMPION PHOENIX trial have tried to elucidate the role of cangrelor in PCI, including its usefulness during a 2-hour landmark analysis, impact on intraprocedural stent thrombosis, and reduction in myocardial infarction (MI) rate. The influence of gender, geographic region, access site, and bivalirudin use on cangrelor\u2019s effects has also been reported. In patients with ST elevation MI and in clinical scenarios of disturbed absorption of oral antiplatelet agents or in need of an intravenous agent, cangrelor may surpass oral agents\u2019 drawbacks. Transitioning to an oral agent is mandatory following cangrelor infusion discontinuation, although ticagrelor may be administered earlier without any pharmacodynamic interaction. Nevertheless, the clinical role of cangrelor in conjunction with administration of prasugrel or ticagrelor remains unclear. Accruing real-life experience is expected to improve our understanding of cangrelor\u2019s role in everyday clinical practice.\n                  <\/jats:p>","DOI":"10.1177\/1074248417715004","type":"journal-article","created":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T05:14:20Z","timestamp":1497503660000},"page":"13-22","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["Cangrelor in Percutaneous Coronary Intervention: Current Status and Perspectives"],"prefix":"10.1177","volume":"23","author":[{"given":"Dimitrios","family":"Alexopoulos","sequence":"first","affiliation":[{"name":"2nd Department of Cardiology, Attikon University Hospital, National and Capodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Pappas","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology, Attikon University Hospital, National and Capodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danai","family":"Sfantou","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology, Attikon University Hospital, National and Capodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lekakis","sequence":"additional","affiliation":[{"name":"2nd Department of Cardiology, Attikon University Hospital, National and Capodistrian University of Athens Medical School, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2017,6,15]]},"reference":[{"key":"bibr1-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61170-8"},{"key":"bibr2-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm545"},{"key":"bibr3-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.912550"},{"key":"bibr4-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.112.972323"},{"key":"bibr5-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009344986"},{"key":"bibr6-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908629"},{"key":"bibr7-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908628"},{"key":"bibr8-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300815"},{"key":"bibr9-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61615-3"},{"key":"bibr10-1074248417715004","first-page":"136","volume":"35","author":"Cavender MA","year":"2014","journal-title":"Eur Heart J"},{"issue":"7","key":"bibr11-1074248417715004","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jacc.2013.10.022","volume":"63","author":"G\u00e9n\u00e9reux P","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"bibr12-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.08.122"},{"key":"bibr13-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020829"},{"key":"bibr14-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.06.046"},{"key":"bibr15-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017300"},{"key":"bibr16-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.116.003612"},{"key":"bibr17-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv498"},{"key":"bibr18-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2014.09.025"},{"key":"bibr19-1074248417715004","first-page":"1233","volume":"37","author":"Eisen A","year":"2016","journal-title":"Insights from the CHAMPION trials. Eur Heart J"},{"key":"bibr20-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.116.004380"},{"key":"bibr21-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.055"},{"key":"bibr22-1074248417715004","unstructured":"KENGREAL (cangrelor) for injection. www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/204958lbl.pdf (accessed 23 December 2016)."},{"key":"bibr23-1074248417715004","unstructured":"Kengrexal, INN-cangrelor tetrasodium \u2013 European Medicines Agency. www.ema.europa.eu\/docs\/\u2026\/WC500188098.pdf (accessed 23 December 2016)."},{"key":"bibr24-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv320"},{"key":"bibr25-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.50788"},{"key":"bibr26-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.08.053"},{"key":"bibr27-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.02.012"},{"key":"bibr28-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvw005"},{"key":"bibr29-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2014.02.004"},{"key":"bibr30-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.001593"},{"key":"bibr31-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.116.004229"},{"key":"bibr32-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308963"},{"key":"bibr33-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.04.012"},{"key":"bibr34-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-015-0320-0"},{"key":"bibr35-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.02.045"},{"key":"bibr36-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407024"},{"key":"bibr37-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04046.x"},{"key":"bibr38-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2016.1246714"},{"key":"bibr39-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.08.270"},{"key":"bibr40-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.11.017"},{"key":"bibr41-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-013-6474-9"},{"key":"bibr42-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1177\/1074248412467692"},{"key":"bibr43-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-012-6436-7"},{"key":"bibr44-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3466.2007.00027.x"},{"key":"bibr45-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.05.020"},{"key":"bibr46-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1111\/joic.12229"},{"key":"bibr47-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000000158"},{"key":"bibr48-1074248417715004","doi-asserted-by":"publisher","DOI":"10.3109\/09537104.2015.1069809"},{"key":"bibr49-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.08.017"},{"key":"bibr50-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.4556"},{"key":"bibr51-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1007\/BF03086246"},{"key":"bibr52-1074248417715004","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.11.019"}],"container-title":["Journal of Cardiovascular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1074248417715004","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1074248417715004","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1074248417715004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:42:40Z","timestamp":1777394560000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1074248417715004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,15]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1177\/1074248417715004"],"URL":"https:\/\/doi.org\/10.1177\/1074248417715004","relation":{},"ISSN":["1074-2484","1940-4034"],"issn-type":[{"value":"1074-2484","type":"print"},{"value":"1940-4034","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,15]]}}}